Community-Acquired Pneumonia clinical trials
9 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
- Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study
- Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
- Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
- OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Community-Acquired Pneumonia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.